Los Angeles, CA and Vancouver, BC, May 28, 2025 - BioSig Technologies, Inc. (Nasdaq: BSGM) and Streamex Exchange Corporation have successfully completed their previously disclosed share exchange transaction. The merger forms a company specializing in the tokenization of real-world assets, particularly focusing on commodities. Streamex will become a wholly owned subsidiary of BioSig, with Streamex Co-Founder and CEO Henry McPhie taking the helm as CEO of the combined company. Morgan Lekstrom, Co-Founder and Chairman of Streamex, will serve as Chairman of the Board. Anthony Amato, the current CEO of BioSig, will transition to a role on the Board of Directors. The move is aimed at accelerating growth and scaling technology in the tokenization and commodities industries.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。